BLC
BSX icon

Brown, Lisle/Cummings’s Boston Scientific BSX Stock Holding History

Brown, Lisle/Cummings’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Buy
77,778
+2,015
+3% +$109K 0.74% 33
2026
Q1 		$4.75M Buy
75,763
+1,320
+2% +$106K 1.19% 20
2025
Q4 		$7.1M Sell
74,443
-900
-1% -$88.2K 1.75% 10
2025
Q3 		$7.36M Sell
75,343
-225
-0.3% -$23.3K 1.89% 8
2025
Q2 		$8.12M Buy
75,568
+1,175
+2% +$119K 2.16% 7
2025
Q1 		$7.5M Sell
74,393
-132
-0.2% -$13.3K 2.18% 8
2024
Q4 		$6.66M Buy
74,525
+833
+1% +$73.3K 1.99% 8
2024
Q3 		$6.18M Buy
73,692
+75
+0.1% +$5.91K 1.88% 9
2024
Q2 		$5.67M Buy
73,617
+250
+0.3% +$18.3K 1.85% 10
2024
Q1 		$5.02M Buy
73,367
+1,250
+2% +$80.4K 1.71% 11
2023
Q4 		$4.17M Sell
72,117
-100
-0.1% -$5.34K 1.55% 11
2023
Q3 		$3.81M Buy
72,217
+2,525
+4% +$132K 1.73% 12
2023
Q2 		$3.77M Buy
69,692
+6,625
+11% +$346K 1.69% 13
2023
Q1 		$3.16M Buy
63,067
+975
+2% +$46K 1.6% 14
2022
Q4 		$2.87M Buy
62,092
+1,275
+2% +$55.2K 1.54% 13
2022
Q3 		$2.36M Sell
60,817
-1,000
-2% -$40.1K 1.38% 17
2022
Q2 		$2.3M Buy
61,817
+2,475
+4% +$101K 1.28% 20
2022
Q1 		$2.63M Buy
59,342
+5,225
+10% +$226K 1.26% 20
2021
Q4 		$2.3M Buy
+54,117
New +$2.27M 1.15% 20

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Brown, Lisle/Cummings's BSX Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its Boston Scientific (BSX) stake by 2.7% in Q2 2026, buying an estimated $109K and bringing the position to 77,778 shares worth $3.32M. The position accounts for 0.74% of the portfolio, ranked #33.

Brown, Lisle/Cummings first reported a position in BSX in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.12M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Brown, Lisle/Cummings held 77,778 shares of Boston Scientific worth $3.32M as of Q2 2026.
  • Brown, Lisle/Cummings bought 2,015 Boston Scientific shares in Q2 2026, an estimated $109K.
  • Boston Scientific made up 0.74% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #33 holding.
  • Brown, Lisle/Cummings first reported a position in Boston Scientific in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Boston Scientific position peaked at $8.12M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.